iBio, Inc. entered into an At Market Issuance Sales Agreement with Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC for the sale of its common stock.
AI Assistant
IBIO INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.